My understanding of the need for diversity in clinical research comes from first-hand experience.
Elevating the unheard voices of diverse communities is the focus of a recent collaboration between Chase’s organization GRYT Health and Bristol Myers Squibb, which recently launched a disparities-focused virtual platform called Diversity in Oncology.
The Partnership Director at GRYT Health opened up about their collaboration with Bristol Myers Squibb to address disparities in clinical trials.
Dave Craig, two-time cancer survivor, co-founder and CEO of GRYT Health, a digital oncology company that empowers people to be in charge of their own health through education, engagement and support, discusses the partnership with Bristol Myers Squibb to host the third annual Global Virtual Cancer Conference (GVCC) November 11-13, 2021.
GRYT Health, a digital oncology company, is continuing it’s multiyear partnership with Bristol Myers Squibb and is launching a new virtual platform, Diversity in Oncology, a four-part series of live, interactive sessions beginning Oct. 27 and running every few weeks through February to highlight and change some long-standing and prevalent disparities.
Read Rochester Business Journal's story about how GRYT Health's advancements aid health care equity.
Read Outsourcing-Pharma's story about The Advocacy Exchange via an interview with Cathy Traz, executive director for BMS Patient Advocacy.
Read The Buffalo News's story about Lori Pohrte and her thoughts on how GRYT Health was the only place that she felt comfortable enough to be open and honest about her experience.
Bristol Myers Squibb’s patient advocacy partnership with GRYT Health is changing its name from the COVID Advocacy Exchange to simply the Advocacy Exchange. The name change shows that the global online service platform for patient advocates and patients is moving from a COVID-19 resource to an everyday one.
On today's episode of The Research Evangelist podcast, meet Cathy Traz and Dave Craig. Cathy is Executive Director, Patient Advocacy at Bristol Myers Squibb. Dave is two-time testicular cancer survivor and co-founder and CEO of GRYT Health. These 2 leaders came together last year to create the COVID Advocacy Exchange, an innovative and bold virtual platform.